Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin’s lymphoma treated with interferon alfa (IFN-α2a) plus an anthracycline-based induction regimen

✍ Scribed by Smalley, R V; Weller, E; Hawkins, M J; Oken, M M; O’Connell, M J; Haase-Statz, S; Borden, E C

• Book ID: 110054927
• Publisher: Nature Publishing Group
• Year: 2001
• Tongue: English
• Weight: 112 KB
• Volume: 15
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2402161